Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NEOG
NEOG logo

NEOG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Neogen Corp (NEOG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.190
1 Day change
-2.85%
52 Week Range
11.430
Analysis Updated At
2026/05/15
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

NEOG is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The setup is mixed to weak: pre-market price is down 1.54%, momentum is negative, and there is no bullish proprietary trading signal. While hedge funds have been aggressive buyers, the lack of recent news, no clear financial update, and no analyst/valuation support make this more of a wait-and-see name than an immediate buy. If the goal is to act now rather than wait for a better entry, the best call is hold, not buy.

Technical Analysis

NEOG is in a weak short-term trend. The MACD histogram is negative and widening, indicating downside momentum. RSI_6 at 24.93 is deeply oversold-adjacent but not yet showing a confirmed reversal signal. Moving averages are converging, which suggests indecision rather than a confirmed uptrend. Price is trading below the pivot at 8.975 and near support at 8.513, with deeper support at 8.227. In the current pre-market session at 8.3, the stock is sitting close to support but has not confirmed a rebound. The technical picture favors caution over immediate entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is mixed. The open interest put-call ratio of 0.81 is slightly bullish/neutral, implying calls modestly outweigh puts in positioning. However, the option volume put-call ratio of 56.0 is extremely bearish in tone, showing heavy put activity relative to calls in the latest flow. Implied volatility is elevated at 71.87, above historical volatility of 45.89, suggesting traders are paying up for downside protection or event uncertainty. Overall, options flow leans cautious to bearish in the near term.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
6

Positive Catalysts

  • ["Hedge funds are buying aggressively, with buying up 999.08% over the last quarter.", "The stock is near technical support levels, which could attract dip buyers if a reversal develops.", "RSI is very low, which sometimes precedes a short-term bounce."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no clear event-driven catalyst.", "Pre-market price is down 1.54%, showing weak immediate sentiment.", "MACD momentum is negative and expanding.", "Options flow is heavily skewed toward puts on recent volume.", "No recent congress trading data and no insider buying signal to support the case.", "No valuation data or usable financial snapshot to justify a long-term entry."]

Financial Performance

No reliable latest-quarter financial snapshot was available because of a data error, so there is no confirmed quarter-by-quarter growth assessment to support a buy decision. Since the latest quarter season is not provided, financial momentum cannot be verified from the supplied data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible Wall Street upgrade/downgrade trend to support bullish sentiment. Based on the available information, the pros view is weak to neutral: hedge fund accumulation is a plus, but the cons view is stronger because of negative price momentum, bearish option flow, and no fresh catalyst.

Wall Street analysts forecast NEOG stock price to fall
4 Analyst Rating
Wall Street analysts forecast NEOG stock price to fall
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 8.430
sliders
Low
6.5
Averages
8.17
High
10
Current: 8.430
sliders
Low
6.5
Averages
8.17
High
10
Guggenheim
Buy
maintain
$8 -> $12
AI Analysis
2026-01-09
Reason
Guggenheim
Price Target
$8 -> $12
AI Analysis
2026-01-09
maintain
Buy
Reason
Guggenheim raised the firm's price target on Neogen to $12 from $8 and keeps a Buy rating on the shares after the company beat revenue and EBITDA expectations and raised guidance. While stating that one quarter "does not make a trend," the firm adds that the portfolio performed well and cost actions "clearly are starting to take hold."
CJS Securities
Robert Labick
Market Perform -> Outperform
upgrade
$10
2025-12-10
Reason
CJS Securities
Robert Labick
Price Target
$10
2025-12-10
upgrade
Market Perform -> Outperform
Reason
CJS Securities analyst Robert Labick upgraded Neogen to Outperform from Market Perform with a $10 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NEOG
Unlock Now

People Also Watch